BioXcel Therapeutics (BTAIQ) Net Margin (2022 - 2026)
BioXcel Therapeutics (BTAIQ) reported Net Margin of -8084.07% for Q2 2026, up 7905.10 percentage points from -15989.17% a year earlier but down 1923.39 percentage points from the prior quarter.
BioXcel Therapeutics (BTAIQ) Net Margin (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioXcel Therapeutics' Net Margin came in at -9549.87%, down 3680.05 percentage points year-over-year; for FY2025, it came in at -10887.38%, down 8257.24 percentage points from FY2024.
- Net Margin has a three-year change of +33314.48 percentage points (FY2022 to FY2025).
- By year, Net Margin came in at -2630.14% in FY2024 (+10344.71 pp), -12974.86% in FY2023 (+31227.01 pp) and -44201.87% in FY2022.
- Five-year quarterly Net Margin spans a low of -31541.84% in Q3 2025 and a high of -751.72% in Q2 2024.
- Year over year, Net Margin gained in four of the last eight quarters, with an average year-over-year change of -3075.94 percentage points.
- The high point for year-over-year Net Margin in five years was Q1 2024 (a gain of 21025.86 percentage points); the low point was Q3 2025 (a drop of 25163.33 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -6160.68% (Q1 2026), -4900.39% (Q4 2025) and -31541.84% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 32.99% |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | -8,084.07% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8,084.07% |
| Mar 31, 2026 | -6,160.68% |
| Dec 31, 2025 | -4,900.39% |
| Sep 30, 2025 | -31,541.84% |
| Jun 30, 2025 | -15,989.17% |
| Mar 31, 2025 | -4,317.86% |
| Dec 31, 2024 | -2,966.94% |
| Sep 30, 2024 | -6,378.50% |
| Jun 30, 2024 | -751.72% |
| Mar 31, 2024 | -4,603.26% |
| Dec 31, 2023 | -5,919.15% |
| Sep 30, 2023 | -14,805.28% |
| Jun 30, 2023 | -11,710.07% |
| Mar 31, 2023 | -25,629.13% |
| Dec 31, 2022 | -23,028.57% |
| Sep 30, 2022 | -30,514.60% |
BioXcel Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();